Literature DB >> 21521266

Uterus and ovaries in girls and young women with Turner syndrome evaluated by ultrasound and magnetic resonance imaging.

Line Cleemann1, Kirsten Holm, Eva Fallentin, Svend Oluf Skouby, Heidi Smedegaard, Nini Møller, Hanne Borch-Christensen, Eva Mosfeldt Jeppesen, Steen Bo Wieslander, Anna-Maria Andersson, Arieh Cohen, Claus Højbjerg Gravholt.   

Abstract

OBJECTIVE: To determine uterine and ovarian size in Turner syndrome (TS) and to compare uterine and ovarian size evaluated by transabdominal ultrasound (US) and magnetic resonance imaging (MRI) in girls with TS and two groups of controls.
DESIGN: A cross-sectional study. PATIENTS: Forty-one girls with TS (17·0 ± 3·3 years, range 11·2-24·9 years), 50 healthy age-matched controls (16·9 ± 3·2 years, range 12·5-25·0 years) and 107 Tanner-stage-matched controls (15·0 ± 3·2 years, range 10·1-24·2). MEASUREMENTS: Uterine and ovarian volume by US and MRI.
RESULTS: Ovaries were detected in 37% in TS by US and in 55% in TS by MRI (P = 0·1). Total ovarian volume was lower in TS compared to both groups of controls (TS vs C-US: median 1·1 ml (range 0·1-29·3) vs 11·52 ml (1·9-77·9), P = 0·001, TS vs C-MRI: 1·0 ml (0·1-34·2) vs 13·2 ml (2·4-30·1), P < 0·0005). Mean difference in total ovarian volume measured by MRI and US in patients with TS was 2·3 ± 3·8 ml (P = 0·01). Mean uterine volume by MRI was lower in TS compared to controls (29·5 ± 25·1 vs 54·3 ± 23·3 ml, P < 0·0005). Uterine volume by US was lower in TS at Tanner stage B5 compared to controls (TS vs C: 33·6 ± 18·2 vs 50·2 ± 18·0 ml, P = 0·007).
CONCLUSIONS: A larger ovarian volume was detected by MRI in TS compared to US. This finding is important with the advancements of performing ovarian biopsies for cryopreservation and later reimplantation. Mean uterine volumes by MRI and US in fully matured TS were lower compared to controls despite appropriate hormonal replacement therapy in TS.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21521266     DOI: 10.1111/j.1365-2265.2011.03995.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

Review 1.  Sex hormone replacement in Turner syndrome.

Authors:  Christian Trolle; Britta Hjerrild; Line Cleemann; Kristian H Mortensen; Claus H Gravholt
Journal:  Endocrine       Date:  2011-12-07       Impact factor: 3.633

Review 2.  The patient with Turner syndrome: puberty and medical management concerns.

Authors:  Luisa Gonzalez; Selma Feldman Witchel
Journal:  Fertil Steril       Date:  2012-08-09       Impact factor: 7.329

Review 3.  The Care of Adolescents and Young Adults with Turner Syndrome: A Pediatric and Adolescent Gynecology Perspective.

Authors:  Tazim Dowlut-McElroy; Roopa Kanakatti Shankar
Journal:  J Pediatr Adolesc Gynecol       Date:  2022-03-08       Impact factor: 2.046

4.  The predictive role of pelvic magnetic resonance in the follow up of spontaneous or induced puberty in turner syndrome.

Authors:  M C Maggio; A De Pietro; P Porcelli; F Serraino; T Angileri; A Di Peri; G Corsello
Journal:  Ital J Pediatr       Date:  2018-02-13       Impact factor: 2.638

5.  Late-Onset Puberty Induction by Transdermal Estrogen in Turner Syndrome Girls-A Longitudinal Study.

Authors:  Aneta Monika Gawlik; Magdalena Hankus; Kamila Szeliga; Aleksandra Antosz; Tomasz Gawlik; Kamil Soltysik; Agnieszka Drosdzol-Cop; Krzysztof Wilk; Grzegorz Kudela; Tomasz Koszutski; Ewa Malecka-Tendera
Journal:  Front Endocrinol (Lausanne)       Date:  2018-02-08       Impact factor: 5.555

6.  ESR1 polymorphism (rs2234693) influences femoral bone mass in patients with Turner syndrome.

Authors:  Renata C Scalco; Ericka B Trarbach; Edoarda V A Albuquerque; Thais K Homma; Thais H Inoue-Lima; Mirian Y Nishi; Berenice B Mendonca; Alexander A L Jorge
Journal:  Endocr Connect       Date:  2019-11       Impact factor: 3.335

7.  Uterine Development During Induced Puberty in Girls with Turner Syndrome.

Authors:  Monika Obara-Moszynska; Lukasz Dzialach; Barbara Rabska-Pietrzak; Marek Niedziela; Karina Kapczuk
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-06       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.